Birger Sørensen

Birger Sørensen

Chief Executive Officer

  • Cand.real /MSc, Physical Chemistry (minors: Mathematics and Biochemistry), University of Tromsø.
  • Founder President and CEO of original Bionor Immuno AS (2000).
  • Chairman of the Norwegian Bio Industry Association (2006 -2010).
  • EVP and Head of Vaccines Bionor Pharma ASA, Directed vaccine R&D – 31 peer-reviewed publications and a range of patents covering Vacc-4x and Vacc-C5

Andres Schjønhaug Susrud

Executive Vice President

  • MSc, Statistics – Modelling & data analysis (minors: Financial mathematics, insurance mathematics & risk), University of Oslo.
  • Co-founder of Immunor AS (2014)
  • Actuarial consultant 2012-2017 (Deloitte 2013-2017)
  • Financial Controller W.R Berkley Insurance Europe Nordic (2017-2020)
Per Bengtsson

Per Bengtsson

Chief Medical Officer

Former CMO Bionor Immuno AS, former CEO Karobio, Sweden

Dag Arne Wivelstad

Dag Arne Wivelstad

Chief Financial Officer

  • Siv.ok, BI, Oslo and MBA Finance, University of Wisconsin, Madison – the USA
  • Former Alfred Berg, ABG Sundal Collier, and SEB Enskilda
  • Investor and project developer

Aslak Aslaksen

Chief Operating Officer

  • Aslak Aslaksen holds Master of Law degrees from the University of Oslo and Harvard Law School.
  • Extensive experience as a partner in law firms.
  • Investor and project developer in Renewable Energy, Biotech, Mining & Minerals.
  • Member of Oslo City Council 2007 – 2015.